Study: CBD administration associated with reduced cannabis/tobacco use


Paris, France: Vaping a liquid formulation of CBD is associated with reduced cannabis/tobacco use, according to data published in the journal Frontiers in psychiatry.

A team of French investigators assessed the impact of vaporized CBD on daily cannabis consumption habits in a cohort of 20 daily users. Almost all of the study subjects smoked cannabis mixed with tobacco in the joints. Previous studies have already shown that the administration of CBD reduces the smoker’s desire to smoke cigarettes.

Of the nine patients who completed the 12-week trial, six of them reduced their daily cannabis/tobacco joint consumption by 50%.

The authors concluded: “This research provides evidence in favor of the use of CBD in CUD [patients with cannabis use disorder] … and illustrates the interest of proposing an addictological intervention targeting both tobacco and cannabis addiction among co-consumers. …A double-blind, randomized, multicenter, placebo-controlled clinical trial is still needed to assess the effectiveness of inhaled CBD in CUD.

CBD consumption has previously been associated with reductions in alcohol consumption as well as reductions in cue-induced cravings and anxiety in subjects with a history of heroin use.

The full text of the study, “Efficacy of Inhaled Cannabidiol in Cannabis Use Disorder: The Cannavap Pilot Study,” appears in Frontiers in Psychiatry.


Comments are closed.